11C-UCB-J PET定量监测氯胺酮对皮质酮小鼠焦虑抑郁模型突触密度的影响
该研究在皮质酮(CORT)小鼠焦虑抑郁模型中,用靶向SV2A的11C-UCB-J PET成像监测氯胺酮诱导的突触密度变化。CORT小鼠全脑11C-UCB-J结合降低提示突触丢失;单次氯胺酮24小时 behavioral 有抗抑郁效应但PET结合无显著变化;重复给药3周后结合恢复至健康对照水平,且与延迟行为学抗抑郁效应相关。
要点
- CORT小鼠全脑11C-UCB-J结合降低,提示突触丢失。
- 单次氯胺酮24小时行为学抗抑郁但11C-UCB-J结合无显著变化。
- 重复给药3周后11C-UCB-J结合恢复至健康对照水平并与延迟行为效应相关。
核心结论
- 结果支持SV2A PET成像的分子解释可用于监测药物诱导的突触生成,并作为抗抑郁疗效的决定因素。
研究设计与样本
- 研究使用雄性CORT小鼠焦虑抑郁模型与健康对照小鼠,分别接受单次氯胺酮10 mg/kg腹腔注射或重复给药方案(共3剂)。
- 单次给药后24小时或重复给药后1周或3周进行脑PET成像,估计各条件下11C-UCB-J的结合。
主要发现
- 与对照小鼠相比,CORT小鼠全脑11C-UCB-J结合降低,指示突触丢失。
- CORT小鼠单次氯胺酮24小时后行为实验显示抗抑郁效应,但该时间点11C-UCB-J结合无显著变化。
- 重复给药方案3周后,氯胺酮使CORT小鼠11C-UCB-J结合恢复至年龄匹配的未治疗健康对照水平。
- 突触丢失的逆转与行为测试中延迟出现的抗抑郁效应相关。
- 不同条件下离体SV2A蛋白表达与体内11C-UCB-J结合及突触后标志物PSD95强相关。
临床怎么用
- SV2A PET成像可作为转化方法监测氯胺酮诱导的突触生成。
- 氯胺酮的抗抑郁行为效应与突触密度恢复存在时间分离,提示PET监测可能辅助评估疗效时间窗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ketamine was shown to promote synaptogenesis, which is thought to account for its antidepressant effects through the restoration of lost synaptic connections observed in depression. PET imaging using 11C-UCB-J, a radiotracer targeting the synaptic vesicle protein 2 A (SV2A), was investigated as a translational method to monitor ketamine-induced changes in synaptic density in the corticosterone (CORT) mouse model of anxiety/depression. Male CORT and healthy control mice received either a single dose of ketamine (10 mg/kg, i.p) or a repeated-dose regimen (3 doses in total). Brain PET imaging was performed either 24 h after the single dose or 1 or 3 weeks after the repeated-dose regimen to estimate the binding of 11C-UCB-J in each condition. A global decrease in the binding of 11C-UCB-J was observed in CORT mice compared to control mice, indicating synaptic loss. In CORT mice, behavioral experiments showed antidepressant effects of ketamine 24 h after a single dose, although no significant changes in 11C-UCB-J binding could be observed at this time point. Three weeks after the repeated dose regimen, ketamine restored the binding of 11C-UCB-J in CORT mice to the level of age-matched untreated healthy controls. The reversal of synaptic loss was associated with delayed antidepressant effects in behavioural tests. Ex vivo expression of SV2A protein measured under different conditions was strongly correlated with the in vivo binding of 11C-UCB-J and the postsynaptic marker PSD95. These results support the molecular interpretation of SV2A PET imaging to monitor drug-induced synaptogenesis as a determinant of antidepressant efficacy from a translational perspective.
引用
- Corvo C, Goutal S, Mendez-David I, et al. Quantitative monitoring of ketamine's impact on synaptic density using 11C-UCB-J PET imaging in the corticosterone mouse model of anxiety/depression. Mol Psychiatry. 2025. PMID: 41254323. doi:10.1038/s41380-025-03369-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。